thiorphan has been researched along with Cardiomyopathies, Primary in 1 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with thiorphan (10 mg/kg i." | 1.28 | Effect of endopeptidase 24.11 inhibition in conscious cardiomyopathic hamsters. ( Blaine, EB; McGraw, DE; Smits, GJ; Trapani, AJ, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smits, GJ | 1 |
| McGraw, DE | 1 |
| Trapani, AJ | 1 |
| Blaine, EB | 1 |
1 other study available for thiorphan and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Effect of endopeptidase 24.11 inhibition in conscious cardiomyopathic hamsters.
Topics: Animals; Atrial Natriuretic Factor; Cardiomyopathies; Cricetinae; Heart Failure; Male; Neprilysin; S | 1990 |